Clinical Trial Update: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing fixed-dose combinations of telmisartan/amlodipine at 80/10 and 40/10 versus amlodipine 10 in resistant hypertension completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-12-22